The acetylation-defective mutant referred to as p533KR fails to induce apoptosis and cell cycle arrest; however, the tumor suppression capacity is retained by p533KR as a wild-type p53, suggesting an additional pathway that mediates tumor development. Here, TP53 is linked to neoplasm.